Development of a dual MDM2/xiap inhibitor with a high therapeutic index for childhood cancers
Ended Project Grant Awarded Last action
- Award ID
- R43CA246788
- Recipient
-
Seak Therapeutics, LLC UEI HBTSD5J8NL84
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $354,823
Award facts
- Assistance listing
- 93.395 Cancer Treatment Research
- Completion date
- Place of performance
- Memphis, TN 38103, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $55,000 | |
| Original award | $299,823 |
Quick answers
Who received award R43CA246788?
R43CA246788 was awarded to Seak Therapeutics, LLC by National Cancer Institute (National Institutes of Health) on August 1, 2020.
How much is award R43CA246788 worth?
$354,823 has been obligated on R43CA246788.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award